BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 29440574)

  • 1. Glycan-Glycan Interaction Determines
    Belotserkovsky I; Brunner K; Pinaud L; Rouvinski A; Dellarole M; Baron B; Dubey G; Samassa F; Parsot C; Sansonetti P; Phalipon A
    mBio; 2018 Feb; 9(1):. PubMed ID: 29440574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of
    Pinaud L; Samassa F; Porat Z; Ferrari ML; Belotserkovsky I; Parsot C; Sansonetti PJ; Campbell-Valois FX; Phalipon A
    Proc Natl Acad Sci U S A; 2017 Sep; 114(37):9954-9959. PubMed ID: 28847968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical determinants of human neutrophil peptide 1 for enhancing host epithelial adhesion of Shigella flexneri.
    Liao C; Fang K; Xiao J; Zhang W; Zhang B; Yuan W; Lu W; Xu D
    Cell Microbiol; 2019 Oct; 21(10):e13069. PubMed ID: 31218775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycan:glycan interactions: High affinity biomolecular interactions that can mediate binding of pathogenic bacteria to host cells.
    Day CJ; Tran EN; Semchenko EA; Tram G; Hartley-Tassell LE; Ng PS; King RM; Ulanovsky R; McAtamney S; Apicella MA; Tiralongo J; Morona R; Korolik V; Jennings MP
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7266-75. PubMed ID: 26676578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial adhesion and host cell factors leading to effector protein injection by type III secretion system.
    Bohn E; Sonnabend M; Klein K; Autenrieth IB
    Int J Med Microbiol; 2019 Jul; 309(5):344-350. PubMed ID: 31178419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shigella impairs T lymphocyte dynamics in vivo.
    Salgado-Pabón W; Celli S; Arena ET; Nothelfer K; Roux P; Sellge G; Frigimelica E; Bousso P; Sansonetti PJ; Phalipon A
    Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4458-63. PubMed ID: 23417297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Shigella flexneri type three secretion system effector IpgD inhibits T cell migration by manipulating host phosphoinositide metabolism.
    Konradt C; Frigimelica E; Nothelfer K; Puhar A; Salgado-Pabon W; di Bartolo V; Scott-Algara D; Rodrigues CD; Sansonetti PJ; Phalipon A
    Cell Host Microbe; 2011 Apr; 9(4):263-72. PubMed ID: 21501826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATP-mediated Erk1/2 activation stimulates bacterial capture by filopodia, which precedes Shigella invasion of epithelial cells.
    Romero S; Grompone G; Carayol N; Mounier J; Guadagnini S; Prevost MC; Sansonetti PJ; Van Nhieu GT
    Cell Host Microbe; 2011 Jun; 9(6):508-19. PubMed ID: 21669399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shigella IpaH Family Effectors as a Versatile Model for Studying Pathogenic Bacteria.
    Ashida H; Sasakawa C
    Front Cell Infect Microbiol; 2015; 5():100. PubMed ID: 26779450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shigella impairs human T lymphocyte responsiveness by hijacking actin cytoskeleton dynamics and T cell receptor vesicular trafficking.
    Samassa F; Ferrari ML; Husson J; Mikhailova A; Porat Z; Sidaner F; Brunner K; Teo TH; Frigimelica E; Tinevez JY; Sansonetti PJ; Thoulouze MI; Phalipon A
    Cell Microbiol; 2020 May; 22(5):e13166. PubMed ID: 31957253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycointeractome of Neisseria gonorrhoeae: Identification of Host Glycans Targeted by the Gonococcus To Facilitate Adherence to Cervical and Urethral Epithelial Cells.
    Semchenko EA; Everest-Dass AV; Jen FE; Mubaiwa TD; Day CJ; Seib KL
    mBio; 2019 Jul; 10(4):. PubMed ID: 31289181
    [No Abstract]   [Full Text] [Related]  

  • 12. Glycan Chains of Gangliosides: Functional Ligands for Tissue Lectins (Siglecs/Galectins).
    Ledeen RW; Kopitz J; Abad-Rodríguez J; Gabius HJ
    Prog Mol Biol Transl Sci; 2018; 156():289-324. PubMed ID: 29747818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shigella and Enteroinvasive Escherichia Coli.
    Belotserkovsky I; Sansonetti PJ
    Curr Top Microbiol Immunol; 2018; 416():1-26. PubMed ID: 30218158
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Brunner K; Samassa F; Sansonetti PJ; Phalipon A
    Hum Vaccin Immunother; 2019; 15(6):1317-1325. PubMed ID: 30964713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IpgB1 is a novel Shigella effector protein involved in bacterial invasion of host cells. Its activity to promote membrane ruffling via Rac1 and Cdc42 activation.
    Ohya K; Handa Y; Ogawa M; Suzuki M; Sasakawa C
    J Biol Chem; 2005 Jun; 280(25):24022-34. PubMed ID: 15849186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gangliosides of the Vertebrate Nervous System.
    Schnaar RL
    J Mol Biol; 2016 Aug; 428(16):3325-3336. PubMed ID: 27261254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new paradigm of bacteria-gut interplay brought through the study of Shigella.
    Sasakawa C
    Proc Jpn Acad Ser B Phys Biol Sci; 2010; 86(3):229-43. PubMed ID: 20228623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the crosstalk between Shigella and T lymphocytes.
    Salgado-Pabón W; Konradt C; Sansonetti PJ; Phalipon A
    Trends Microbiol; 2014 Apr; 22(4):192-8. PubMed ID: 24613405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Do the Virulence Factors of
    Mattock E; Blocker AJ
    Front Cell Infect Microbiol; 2017; 7():64. PubMed ID: 28393050
    [No Abstract]   [Full Text] [Related]  

  • 20. Tips and tricks about Shigella invasion of epithelial cells.
    Carayol N; Tran Van Nhieu G
    Curr Opin Microbiol; 2013 Feb; 16(1):32-7. PubMed ID: 23318141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.